Growth factor control of bone mass.
Growth factor control of bone mass.
复制标题
DOI:
10.1002/jcb.22322
复制
发表时间:
2009-11-01
影响因子:
4
通讯作者:
Canalis, Ernesto
中科院分区:
文献类型:
--
作者:
Canalis, Ernesto
Bone formation is determined by the number and function of osteoblasts. Cell number is governed by factors that regulate the replication and differentiation of pre-osteoblasts and factors that regulate osteoblastic cell death. Cell function is controlled by signals acting on the mature osteoblast. Platelet derived and fibroblast growth factors are bone cell mitogens. Bone morphogenetic proteins (BMP) and Wnt induce the differentiation of mesenchymal cells toward osteoblasts, and insulin-like growth factor (IGF)-I stimulates the function of mature osteoblasts and prevents their death. The activity of BMP, Wnt and IGF-I is modulated by extracellular antagonists or binding proteins. Changes in growth factor synthesis and activity may play a role in the pathogenesis of selected forms of osteoporosis, and alterations in the expression or binding of the extracellular antagonists can be associated with changes in bone mass. Current approaches to bone anabolic therapies for osteoporosis include the administration of a growth factor, such as IGF-I, or the neutralization of an antagonist. Ideally, the targeting of an anabolic agent should be specific to bone to preclude non-skeletal unwanted side effects. Clinical trials are needed to determine the long-term effectiveness and safety of novel anabolic agents for the management of osteoporosis.
登录
查看更多内容
影响因子:
4
作者:
BEAMER, WG;EICHER, EM
通讯作者:
EICHER, EM
影响因子:
15.9
作者:
CANALIS, E
通讯作者:
CANALIS, E
影响因子:
4.8
作者:
Devlin, RD;Du, Z;Canalis, E
通讯作者:
Canalis, E
影响因子:
--
作者:
Bodine, PVN;Zhao, WG;Komm, BS
通讯作者:
Komm, BS
影响因子:
4.8
作者:
Akeno, N;Robins, J;Clemens, TL
通讯作者:
Clemens, TL